Key figures
2020 revenue: 1,837.4 million euros
Renewed organic growth in Q4: +1.4%
Performance by region
| In millions of euros | 2020 revenue | Contribution | Change 2020/2019 | Organic growth |
| Europe, Middle East and Africa | 860.2 | 47% | 0.1% | 2% |
| Americas | 663.9 | 36% | (13.8)% | (12)% |
| Asia-Pacific | 313.3 | 17% | (16.2)% | (14)% |
| Full-year revenues | 1,837.4 | 100% | (8.3)% | (6.5)% |
Performance by audience
| In million of euros | 2020 revenue | Contribution | Total growth 2020/2019 | Organic growth |
| Consumers1 | 765.2 | 42% | (15.2)% | (12.5)% |
| Clients and employees2 | 407.7 | 22% | (20.9)% | (21)% |
| Citizens3 | 346.5 | 19% | 27.7% | 29.5% |
| Doctors and patients4 | 318.0 | 17% | 1.3% | 4% |
| Full-Year Revenues | 1,837.4 | 100% | (8.3)% | (6.5)% |
Breakdown of Service Lines by audience segment:
1- Brand Health Tracking, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market Strategy & Understanding, Observer (excl. public sector), Social Intelligence Analytics
2- Automotive & Mobility Development, Audience Measurement, Customer Experience, Channel Performance (including Retail Performance and Mystery Shopping), Media development
3- Public Affairs, Corporate Reputation
4- Pharma (quantitative and qualitative)
Summary consolidated financial statement
|
In million of euros |
2020 | 2019 |
| Revenue | 1,873.4 | 2,003.3 |
| Gross profit | 1,180.5 | 1,288.5 |
| Operating margin | 189,9 | 198.7 |
| Adjusted net profit*, attributable to the Group | 129,6 | 129.5 |
| Workforce as of 31 December | 16,644 | 18,448 |
*Adjusted net profit is calculated before (i) non-cash items related to IFRS 2 (share-based compensation), (ii) amortisation of acquisition-related intangible assets (client relations), (iii) the impact net of tax of other noncurrent income, (iv) expense and the non-monetary impact of changes in puts in other financial income and expenses, (v) deferred tax liabilities related to goodwill for which amortisation is deductible in some countries.
Financial statement
| In million of euros | 2020 | 2019 |
| Total shareholders' equity | 1,122 | 1,123 |
| Financial debt | 347 | 578 |
| Free cash flow | 265,1 | 64.3 |
| Net debt / EBITDA | x2,4 | x 2.4 |
| Net gearing | 30,9% | 51.5% |
Share capital and voting rights as at 31 December 2019
| Number of shares | % | Number of voting rights | % | |
| DT & Partners | 4,406,988 | 9.92 | 8,813,976 | 17.74 |
| Didier Truchot | 272,550 | 0.61 |
529,693 |
1.07 |
| Public | 37,912,134 | 85.32 | 38,103,000 | 76.68 |
| Employees | 1,368,583 | 3.08 | 2,244,894 | 4.52 |
| --> Including FCPE and Group savings plan | 24,670 | 0.05 | 47,838 | 0.10 |
| Treasury shares | 475,980 | 1.07 | 0 | 0.00% |
| --> Of which liquidity agreement | 10,004 | 0.02 | 0 | 0.00% |
| Total | 44,436,235 | 100 | 49,691,563 | 100 |
Dividends history
| Financial year | Net dividend per share |
| 2020 | 0.90€ |
| 2019 | 0.45€ |
| 2018 | 0.88€ |
| 2017 | 0.87€ |
| 2016 | 0.85€ |
| 2015 | 0.80€ |
| 2014 | 0.75€ |
| 2013 | 0.70€ |
| 2012 | 0.64€ |